nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A1—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.0482	0.0491	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—KCNJ5—adrenal gland cancer	0.033	0.0336	CbGpPWpGaD
Disopyramide—SLC22A2—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.0297	0.0303	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—KCNJ5—adrenal gland cancer	0.0294	0.03	CbGpPWpGaD
Disopyramide—SLC22A1—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.0277	0.0282	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.0167	0.017	CbGpPWpGaD
Disopyramide—Fesoterodine—ABCB1—adrenal gland cancer	0.0152	0.824	CrCbGaD
Disopyramide—CHRM1—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0145	0.0148	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Other—GNRHR—adrenal gland cancer	0.0143	0.0146	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0142	0.0145	CbGpPWpGaD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.0133	0.0135	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—PRKACA—adrenal gland cancer	0.0127	0.0129	CbGpPWpGaD
Disopyramide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.012	0.0122	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—PRKACA—adrenal gland cancer	0.0113	0.0115	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0097	0.00988	CbGpPWpGaD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00967	0.00985	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00957	0.00975	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00887	0.00904	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00827	0.00843	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00809	0.00824	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00806	0.00821	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00723	0.00737	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00721	0.00735	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00686	0.00699	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—BRAF—adrenal gland cancer	0.00682	0.00695	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—KCNJ5—adrenal gland cancer	0.0068	0.00693	CbGpPWpGaD
Disopyramide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00654	0.00666	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—KCNJ5—adrenal gland cancer	0.00634	0.00646	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.00628	0.0064	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—NR5A1—adrenal gland cancer	0.00622	0.00634	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—BRAF—adrenal gland cancer	0.00608	0.00619	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00536	0.00546	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00534	0.00544	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00529	0.00539	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00509	0.00519	CbGpPWpGaD
Disopyramide—CHRM3—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00494	0.00503	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00484	0.00494	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00483	0.00492	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00433	0.00441	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00432	0.0044	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00408	0.00416	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00407	0.00414	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00403	0.0041	CbGpPWpGaD
Disopyramide—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.004	0.00408	CbGpPWpGaD
Disopyramide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00394	0.00402	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—TP53—adrenal gland cancer	0.0038	0.00387	CbGpPWpGaD
Disopyramide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00376	0.00383	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MED12—adrenal gland cancer	0.00374	0.00381	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00372	0.00379	CbGpPWpGaD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.0037	0.00377	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00367	0.00374	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00354	0.0036	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0034	0.00346	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00332	0.00339	CbGpPWpGaD
Disopyramide—Methadone—ABCB1—adrenal gland cancer	0.00325	0.176	CrCbGaD
Disopyramide—SCN5A—Axon guidance—CDC42—adrenal gland cancer	0.00324	0.0033	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00321	0.00327	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0032	0.00326	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00317	0.00323	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00317	0.00323	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00315	0.00321	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00314	0.0032	CbGpPWpGaD
Disopyramide—SCN5A—L1CAM interactions—EGFR—adrenal gland cancer	0.00312	0.00318	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00311	0.00317	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00301	0.00307	CbGpPWpGaD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.003	0.00306	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00297	0.00303	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00286	0.00291	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00285	0.0029	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00282	0.00288	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00267	0.00272	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—PRKACA—adrenal gland cancer	0.00261	0.00265	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00244	0.00249	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00244	0.00248	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—PRKACA—adrenal gland cancer	0.00243	0.00247	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00241	0.00246	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	0.00231	0.00236	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0023	0.00235	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0023	0.00234	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00228	0.00232	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00218	0.00222	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00217	0.00221	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00215	0.00219	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00209	0.00213	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00209	0.00213	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00207	0.00211	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00207	0.0021	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.002	0.00204	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.002	0.00203	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00198	0.00201	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SDHB—adrenal gland cancer	0.00187	0.00191	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00183	0.00187	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SDHB—adrenal gland cancer	0.00174	0.00178	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00171	0.00174	CbGpPWpGaD
Disopyramide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00164	0.00167	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00161	0.00164	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—BRAF—adrenal gland cancer	0.0014	0.00143	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.0014	0.00143	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00139	0.00142	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00138	0.00141	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00138	0.0014	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00138	0.0014	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00136	0.00139	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00133	0.00135	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—BRAF—adrenal gland cancer	0.00131	0.00133	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00131	0.00133	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00127	0.00129	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00126	0.00129	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00125	0.00128	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00125	0.00127	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00125	0.00127	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00124	0.00126	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00124	0.00126	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00123	0.00126	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00123	0.00125	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00123	0.00125	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00122	0.00124	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00121	0.00124	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—RRM1—adrenal gland cancer	0.00121	0.00123	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SDHD—adrenal gland cancer	0.00121	0.00123	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—EGFR—adrenal gland cancer	0.00118	0.0012	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00115	0.00117	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00115	0.00117	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00115	0.00117	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00114	0.00116	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00114	0.00116	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00113	0.00116	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00113	0.00115	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SDHD—adrenal gland cancer	0.00112	0.00115	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—RRM1—adrenal gland cancer	0.00112	0.00115	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00112	0.00114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00112	0.00114	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00112	0.00114	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00111	0.00113	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00111	0.00113	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00111	0.00113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.0011	0.00112	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00108	0.0011	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00108	0.0011	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00107	0.00109	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00106	0.00108	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00106	0.00108	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MED12—adrenal gland cancer	0.000899	0.000916	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000855	0.000871	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000853	0.000869	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000853	0.000869	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00085	0.000866	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.000842	0.000858	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	0.000841	0.000857	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MED12—adrenal gland cancer	0.000838	0.000854	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000802	0.000817	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0008	0.000815	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000792	0.000807	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MED12—adrenal gland cancer	0.000774	0.000789	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000758	0.000772	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000749	0.000763	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000747	0.000761	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000741	0.000755	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00074	0.000753	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000738	0.000752	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000731	0.000745	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000716	0.000729	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000714	0.000727	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000707	0.00072	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000705	0.000718	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00068	0.000693	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000678	0.000691	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000677	0.00069	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000675	0.000688	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000672	0.000684	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000669	0.000681	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00066	0.000673	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.000658	0.00067	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	0.000656	0.000668	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000652	0.000664	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00065	0.000662	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000648	0.00066	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000642	0.000654	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00063	0.000642	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000621	0.000632	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.000619	0.00063	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000613	0.000624	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	0.000611	0.000623	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000565	0.000575	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GNAS—adrenal gland cancer	0.000532	0.000542	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	0.000522	0.000532	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GNAS—adrenal gland cancer	0.000496	0.000505	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	0.000486	0.000495	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000482	0.000491	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.00048	0.00049	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000476	0.000485	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000474	0.000483	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000472	0.000481	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000468	0.000477	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000458	0.000466	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000449	0.000458	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000438	0.000446	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000436	0.000445	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000432	0.00044	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000406	0.000414	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000406	0.000414	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000402	0.000409	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000401	0.000408	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000397	0.000404	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000387	0.000395	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000386	0.000393	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000384	0.000391	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000383	0.00039	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000382	0.00039	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000379	0.000386	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000375	0.000382	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000373	0.00038	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.00037	0.000377	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—adrenal gland cancer	0.000358	0.000365	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—adrenal gland cancer	0.000334	0.00034	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000322	0.000328	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000321	0.000327	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000318	0.000324	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000308	0.000314	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000303	0.000308	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	0.000286	0.000291	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.00028	0.000286	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.00028	0.000285	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000277	0.000282	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	0.000266	0.000271	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000259	0.000263	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000258	0.000263	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000255	0.00026	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000255	0.00026	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000255	0.000259	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000252	0.000257	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000247	0.000252	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000247	0.000251	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000246	0.00025	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000244	0.000249	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000221	0.000225	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000185	0.000188	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000184	0.000187	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000182	0.000186	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000179	0.000182	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000176	0.000179	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000146	0.000149	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000146	0.000148	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000144	0.000147	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000123	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000122	0.000125	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000121	0.000123	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000121	0.000123	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	9.61e-05	9.79e-05	CbGpPWpGaD
